Participate in May 2025 KALDAT Conference

Participate in May 2025 KALDAT Conference
AesMed is proud to share highlights from our recent participation in the KALDAT Conference 2025, hosted by the Korean Association for Laser, Dermatology, and Trichology—a valued partner with whom we’ve built a strong relationship over the past 15 years.
At this year’s event, we were honored to feature a special lecture by Dr. Hyun-Kyung Kim of Mouda Clinic, focusing on AGF39™, AesMed’s flagship cytokine-based therapy for hair loss.
The presentation covered the treatment protocol, clinical application, and scientific data behind AGF39™, showcasing its effectiveness as a next-generation solution for a wide range of alopecia conditions.

Since our founding in 2002, AesMed has been at the forefront of Korea’s alopecia market, leading the industry for over 23 years through constant innovation and scientific advancement. Our core focus on cytokine therapy has enabled us to develop hospital-grade solutions that support real clinical outcomes.
To date, AGF39™ is estimated to have been used in over 5 million procedures in the past 18 years, making it the most widely used mesotherapy solution for hair loss in both Korea and Japan.
AesMed remains committed to supporting doctors, clinics, and patients with proven technologies and clinical evidence. We look forward to meeting the hair science community again soon at the next KALDAT event, as we continue to lead the global advancement of hair and scalp restoration

 ► Learn more at: www.aesmed.co.kr
 ► Stay tuned & subscribe for future updates!